During this panel discussion, healthcare system experts will explore the JCA process and efforts to ensure timely access to innovative healthcare products within this new framework. The discussion will consider the challenges and opportunities presented by the JCA and the potential next steps to best prepare Pharma & Biotech companies to manage the new process.

Stay informed about US Health Policy News

Health Policy Weekly

Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.

Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.

Keep up on key global health technology assessment news

HTA Quarterly

Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.

From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.

Joint Clinical Assessments (JCA)

Watch now: The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe